Company / EPS (Basic)
Protalix BioTherapeutics, Inc. EPS (Basic) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$0.12
FY2025
5-year range
-$1.23 / $0.12
FY2021-FY2025
Trend
+138.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.62 to $0.12 over the past 2 years.
Based on SEC 10-K filings.
0.12 in FY2025.
Improved from $-0.62 to $0.12 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 138.7% year-over-year.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | +138.7% |
| FY2024 | -$0.31 | +50.0% |
| FY2023 | -$0.62 | -181.8% |
| FY2022 | -$0.22 | +82.1% |
| FY2021 | -$1.23 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026